ArticleJournal of diabetes and metabolic disorders2024
Past, present and future trends of sarcopenia research in endocrinology & metabolism research institute:a scientometric study.
Article in Journal of diabetes and metabolic disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcopenia is an important disease that needs attention in the world. The aim of this paper was to quantify the trend of sarcopenia's scientific publications of EMRI (Endocrinology & Metabolism Research Institute, Iran). Methods: All studies and scientific articles on sarcopenia which were affiliated to EMRI and its research centers have been recruited in this review through an inclusive search in web of science until 20th December 2019. The number of documents, publication year, main journals, citations, subject area and co-authorship network of authors were assessed. Results: Totally, 28 documents from EMRI were related to sarcopenia and indexed in the web of science. The number of documents showed an increasing trend. Most publications were "meeting abstract" at prestigious congresses. The top subject area were "epidemiology" and "association with other diseases". The highest cited article was a systematic review study, and the top source was "Diabetes & Metabolic Disorders" Journal. Conclusion: EMRI provides an appropriate face of sarcopenia publications in the world. However, there is a need for more effort in other subject areas of sarcopenia, this study would be helpful for Iranian researchers to conduct better research in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.